Lipe & Dalton Abb Vie Inc. Transaction History

Lipe & Dalton

$198 Million
Q3 2024

A detailed history of Lipe & Dalton transactions in Abb Vie Inc. stock. As of the latest transaction made, Lipe & Dalton holds 25,485 shares of ABBV stock, worth $4.54 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares

25,485

Previous 25,585 0.39%

Holding current value

$4.54 Million

Previous $4.39 Million 14.7%

% of portfolio

2.54%

Previous 2.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $16,384 - $19,933	-100 Reduced 0.39%	25,485 $5.03 Million
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $128,630 - $150,211	-831 Reduced 3.15%	25,585 $4.39 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $25,411 - $28,953	-159 Reduced 0.6%	26,416 $4.81 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $67,424 - $75,935	-490 Reduced 1.81%	26,575 $4.12 Million
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $50,096 - $57,993	-375 Reduced 1.37%	27,065 $4.03 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $1.67 Million - $2.07 Million	-12,570 Reduced 31.42%	27,440 $3.7 Million
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $216,770 - $249,643	-1,499 Reduced 3.61%	40,010 $6.38 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $106,913 - $128,217	-773 Reduced 1.83%	41,509 $6.71 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $33,284 - $38,174	-248 Reduced 0.58%	42,282 $5.68 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $92,755 - $117,923	-674 Reduced 1.56%	42,530 $6.51 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $256,437 - $318,166	-1,943 Reduced 4.3%	43,204 $7 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $134,394 - $170,048	1,251 Added 2.85%	45,147 $6.11 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $385,912 - $438,069	3,627 Added 9.01%	43,896 $4.74 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $15,991 - $17,815	152 Added 0.38%	40,269 $4.54 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $55,446 - $61,040	542 Added 1.37%	40,117 $4.34 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $7,807 - $10,540	97 Added 0.25%	39,575 $4.24 Million
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $58,590 - $68,766	682 Added 1.76%	39,478 $3.46 Million
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $36,905 - $49,384	-503 Reduced 1.28%	38,796 $3.81 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $161,637 - $245,061	2,506 Added 6.81%	39,299 $2.99 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $29,645 - $37,092	411 Added 1.13%	36,793 $3.26 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $1,637 - $1,968	26 Added 0.07%	36,382 $2.76 Million
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $18,790 - $24,018	286 Added 0.79%	36,356 $2.64 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $1.6 Million - $1.88 Million	20,740 Added 135.29%	36,070 $2.91 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $163,485 - $201,621	2,100 Added 15.87%	15,330 $1.41 Million
Q3 2018 Nov 05, 2018	BUY	$88.91 - $98.84 $729,062 - $810,488	8,200 Added 163.02%	13,230 $1.25 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $12,881 - $17,249	-140 Reduced 2.71%	5,030 $476,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $17,912 - $19,642	-200 Reduced 3.72%	5,170 $500,000
Q2 2017 Aug 08, 2017	BUY	N/A	5,370	5,370 $389,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account